Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 674-677

  Li, Hong Xia ^a   Chang, Xin Ming ^a   Song, Zheng Jun ^a   He, Shui Xiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOOXYGENASE 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD34; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL COUNT; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; ENDOTHELIUM CELL; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MALE; PRECANCER; PROTEIN EXPRESSION; SEROSA; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; STOMACH LESION; VASCULAR ENDOTHELIUM;

EID: 0038639199     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.674     Document Type: Article

References (41)

1. Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol 1996; 270: G393-G400
2. Eberhart CE, Dubois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology 1995; 109: 285-301
3. DuBois RN, Awad J, Morrow J, Roberts LJ 2nd, Bishop P. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest 1994; 93: 493-498
4. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF Jr, Blot WJ. Use of aspirin and other nonsteroidal antiinflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 97-102
5. Garcia-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonsteroidal antiinflammatory drugs. Epidemiology 2001; 12: 88-93
6. Morgan G. Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and nonaspirin oesophageal cancers. Gut 1996; 38: 646-648
7. Reeves MJ, Newcomb PA, Trenthan-Dietz A, Storer BE, Remington PL. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 1996; 5: 955-960
8. Thun MJ. NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin North Amer 1996; 25: 333-348
9. Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76: 1116-1119
10. Zhuang ZH, Wang LD. NSAID and digestive tract carcinomas. Shijie Huaren Xiaohua Zazhi 2001; 9: 1050-1053
11. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. Suppression of intestinal polyposis in Apc deta716 knockout mice by inhibition of cyclooxygenase 2(COX-2). Cell 1996; 87: 803-809
12. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increase metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336-3340
13. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerner BM, Masferrer JL, Dannenberg AJ. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinome of the head and neck. Cancer Res 1999; 59: 991-994
14. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999; 59: 987-990
15. Zimmerman KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999; 59: 198-204
16. Shiota G, Okubo M, Noumi T, Noguchi N, Oyama K, Takano Y, Yashima K, Kishimoto Y, Kawasaki H. Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 407-412
17. Shirahama T, Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res 2001; 7: 558-561
18. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000; 89: 2637-2645
19. Wu QM, Li SB, Wang Q, Wang DH, Li XB, Liu CZ. The expression of COX-2 in esophageal carcinoma and its relation to clinicopathologic characteristics. Shijie Huaren Xiaohua Zazhi 2001; 9: 11-14
20. Qiu DK, Ma X, Peng YS, Chen XY. Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma. World J Gastroenterol 2002; 8: 815-817
21. Che X, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Aikou T. Tumor angiogenesis related to growth pattern and lymph node metastasis in early gastric cancer. Chin Med J 1998; 111: 1090-1093
22. Shimoyama S, Kaminishi M. Increased angiogenin expression in gastric cancer correlated with cancer progression. J Cancer Res Clin Oncol 2000; 126: 468-474
23. Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y. Angiogenesis inhibitor, TNP-470, suppresses growth of peritoneal disseminating foci. Hepatogastroenterology 2000; 47: 298-302
24. Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Kuroshima K, Aikou T. Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer. Ann Surg Oncol 1998; 5: 585-589
25. Maehara Y, Hasuda S, Abe T, Oki E, Kakeji Y, Ohno S, Sugimachi K. Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer. Clin Cancer Res 1998; 4: 2129-2134
26. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli Gasparini G. Tumor anginogenesis: A new significant and independent prognostic indicator in early state breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-1887
27. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997; 112: 389-397
28. Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, Evans J, O'Neill G. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts. Gastroenterology 1996; 111: 445-454
29. Uefujk K, Ichikura T, Mochizuki H, Shinomiya N. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J Surg Oncol 1998; 69: 168-172
30. Ratnasinghe D, Tangrea JA, Roth MJ, Dawsey SM, Anver M, Kasprzak BA, Hu N, Wang QH, Taylor PR. Expression of cyclooxygenase-2 in human adenocarcinomas of the gastric cardia and corpus. Oncol Rep 1999; 6: 965-968
31. Lim HY, Joo HJ, Choi JH, Yi JW, Yang MS, Cho DY, Kim H, Nam DK, Lee KB, Kim HC. Increased expression of cyclooxygenase-2 protein human gastric carcinoma. Chin Cancer Res 2000; 6: 519-525
32. Van Rees BP, Saukkonen K, Ristimaki A, Polkowski W, Tytgat GN, Drillenburg P, Offerhaus GJ. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J Pathol 2002; 196: 171-179
33. Ohon R, Yoshinaga K, Fujita T, Hasegawa K, Iseki H, Tsunozaki H, Ichikawa W, Nihei Z, Sugihara K. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 2001; 91: 1876-1881
34. Xue YW, Zhang QF, Zhu ZB, Wang Q, Fu SB. Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma. World J Gastroenterol 2003; 9: 250-253
35. Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y, Shiozaki H, Hori M. Cyclooxygenase-2 overexpressing enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterology 1999; 94: 451-455
36. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 1995; 83: 493-501
37. Form DM, Auebach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med 1983; 172: 214-218
38. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364
39. Masferrer JL, Koki A, Seibert K. COX-2 inhibitors. A new class of antiangiogenetic agents. Ann N Y Acad Sci 1999; 889: 84-86
40. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000; 60: 1306-1311
41. Fukumura D, Jain RK. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev 1998; 17: 77-89